Related Topics

    Webster: News Releases & Feature Stories

    Tracing evolution of chicken flu virus yields insight into origins of deadly H7N9 strain

    Scientists from St. Jude Children’s Research Hospital and China Agricultural University identify the changes in H9N2 flu virus in chickens that could signal emergence of viruses with potential to trigger a pandemic. (Robert Webster, PhD)

    1950s pandemic influenza virus remains a health threat, particularly to those under 50

    St. Jude Children’s Research Hospital scientists report that avian H2N2 influenza A viruses related to 1957-1958 pandemic infect human cells and spread among ferrets; may aid identification of emerging threats. (Dr. Robert Webster)

    Old flu virus still threatens

    St. Jude Children’s Research Hospital scientists warn the flu virus that caused a pandemic in the 1950s remains a threat today. The risk is greatest for those under age 50; this group lacks immunity to the virus.

    Robert Webster, Ph.D., presented with National Foundation for Infectious Diseases award

    Virologist Robert G. Webster, Ph.D., of St. Jude Children’s Research Hospital, is the recipient of the Charles Mérieux Award from the National Foundation for Infectious Diseases (NFID).

    Dr. Webster reflects on career in influenza (video)

    Renowned virologist Robert Webster, Ph.D., was invited to give the 2010 Leeuwenhoek Lecture by the Royal Society in London. The Leeuwenhoek Lecture, named after microscopist Antony van Leeuwenhoek, was established to recognize excellence in the field of microbiology.

    Noted St. Jude virologist presents lecture on pandemic influenza to the Royal Society

    Acclaimed virologist Robert Webster, Ph.D., of St. Jude Children’s Research Hospital, presented the 2010 Leeuwenhoek prize lecture today, a prestigious recognition awarded by the Royal Society in London.

    St. Jude virologist honored by the Royal Society

    Robert Webster, PhD, is recognized by the world’s oldest scientific academy for his contributions to the field of virology.

    Cell discovery might lead to therapies to shrink death toll in flu pandemic

    St. Jude researchers have discovered a key factor of fatal influenza virus infection that suggests a possible new way to treat the disease and to greatly reduce the death toll of a potential worldwide pandemic like the 1918 Spanish flu.

    Cytokine storm issue poses another big H5N1 question

    The cytokine storm is a blizzard of signaling proteins that is generated by various immune system cells as they coordinate an attack on an invading microorganism. If this response runs out of control, it can cause potentially fatal inflammation and damage to the lungs. It has been thought that this is what kills people who are infected with H5N1.

    Control measures fail to stop spread of new H5N1 virus

    A new wave of H5N1 transmission through Asia despite containment measures highlights the need for more information on the movement of the virus into and out of southern China.

    Old vaccine has new tricks

    St. Jude vaccine offers cross-protection in ferrets against different variants of H5N1, suggesting it could be stockpiled for use in the event of a human outbreak.

    H5N1 vaccine could be basis for life-saving stockpile

    Scientists at St. Jude Children's Research Hospital have announced that a vaccine they developed a few years ago against one antigenic variant of the avian influenza virus H5N1 may protect humans against future variants of the virus.

    Wider H5N1 watch needed to prepare for flu pandemic

    The H5N1 avian influenza virus continues to spread from its original source in southern China through transported poultry and bird migration. The virus has now established distinct subpopulations throughout Asia.

    St. Jude scientist named Distinguished Biotechnologist

    Robert G. Webster, Ph.D., who holds the Rose Marie Thomas Chair at St. Jude, has been given the Distinguished Biotechnologist of the Year Award by the New Zealand Biotechnology Association for his work in virology and avian influenza.

    St. Jude conducts first large-scale bird flu genome study

    Unique resources at St. Jude Children's Research Hospital let researchers generate a "gold mine" of data to track evolution of bird flu virus genes and understand how they cooperate to cause disease.

    Webster named Research Leader by Scientific American

    Robert G. Webster, PhD, who holds the Rose Marie Thomas Chair at St. Jude Children's Research Hospital, has been named by Scientific American magazine as a "Research Leader" within the 2005 Scientific American 50...

    Avian flu gaining drug resistance in China

    Resistance to the antiviral drug amantadine is spreading significantly more rapidly among avian influenza viruses of H5N1 subtype in Southeast Asia than in North America.

    Influenza -- World-Class Expertise

    Robert Webster, PhD, world-renowned flu expert and professor of virology uses his St. Jude laboratory to track emerging new flu viruses and guide the development of flu vaccines to stop them.

    Researchers trace evolution of H5N1 virus

    An avian influenza virus that has caused three major outbreaks among poultry and killed several people in East Asia over the past seven years arose through a series of genetic reassortment events with other viruses.

    SARS Epidemic is Not the Last Emerging Disease that Will Threaten World Health

    Robert Webster, PhD, world-renowned virologist at St. Jude Children's Research Hospital, has been interviewed about the threat of infectious diseases by top news organizations around the country.

    Special reverse genetics used for vaccine against H5N1

    Scientists at St. Jude Children's Research Hospital announced today the development of a vaccine against H5N1, a new lethal influenza virus that triggered the World Health Organization (WHO) to declare a pandemic alert in February 2003.